Robert J Glynn
Robert J Glynn
Other namesGlynn RJ, Robert James Glynn
Professor of Medicine
Verified email at
Cited by
Cited by
A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission
JM Guralnik, EM Simonsick, L Ferrucci, RJ Glynn, LF Berkman, DG Blazer, ...
Journal of gerontology 49 (2), M85-M94, 1994
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
PM Ridker, E Danielson, FAH Fonseca, J Genest, AM Gotto Jr, ...
New England journal of medicine 359 (21), 2195-2207, 2008
Antiinflammatory therapy with canakinumab for atherosclerotic disease
PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...
New England journal of medicine 377 (12), 1119-1131, 2017
Variable selection for propensity score models
MA Brookhart, S Schneeweiss, KJ Rothman, RJ Glynn, J Avorn, T Stürmer
American journal of epidemiology 163 (12), 1149-1156, 2006
C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
PM Ridker, RJ Glynn, CH Hennekens
Circulation 97 (20), 2007-2011, 1998
Long-term persistence in use of statin therapy in elderly patients
JS Benner, RJ Glynn, H Mogun, PJ Neumann, MC Weinstein, J Avorn
Jama 288 (4), 455-461, 2002
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
PM Ridker, E Danielson, FAH Fonseca, J Genest, AM Gotto, JJP Kastelein, ...
The Lancet 373 (9670), 1175-1182, 2009
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo …
PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ...
The Lancet 390 (10105), 1833-1842, 2017
Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study
EW Campion, RJ Glynn, LO Delabry
The American journal of medicine 82 (3), 421-426, 1987
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism
PM Ridker, SZ Goldhaber, E Danielson, Y Rosenberg, CS Eby, ...
New England Journal of Medicine 348 (15), 1425-1434, 2003
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial
HD Sesso, JE Buring, WG Christen, T Kurth, C Belanger, J MacFadyen, ...
Jama 300 (18), 2123-2133, 2008
Low-dose methotrexate for the prevention of atherosclerotic events
PM Ridker, BM Everett, A Pradhan, JG MacFadyen, DH Solomon, ...
New England Journal of Medicine 380 (8), 752-762, 2019
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data
S Schneeweiss, JA Rassen, RJ Glynn, J Avorn, H Mogun, MA Brookhart
Epidemiology 20 (4), 512-522, 2009
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
PM Ridker, A Pradhan, JG MacFadyen, P Libby, RJ Glynn
The Lancet 380 (9841), 565-571, 2012
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
BF Gage, C Eby, JA Johnson, E Deych, MJ Rieder, PM Ridker, ...
Clinical Pharmacology & Therapeutics 84 (3), 326-331, 2008
A combined comorbidity score predicted mortality in elderly patients better than existing scores
JJ Gagne, RJ Glynn, J Avorn, R Levin, S Schneeweiss
Journal of clinical epidemiology 64 (7), 749-759, 2011
A randomized trial of rosuvastatin in the prevention of venous thromboembolism
RJ Glynn, E Danielson, FAH Fonseca, J Genest, AM Gotto Jr, ...
New England Journal of Medicine 360 (18), 1851-1861, 2009
Reduction of bacteriuria and pyuria after ingestion of cranberry juice
J Avorn, M Monane, JH Gurwitz, RJ Glynn, I Choodnovskiy, LA Lipsitz
Jama 271 (10), 751-754, 1994
Increased pulse pressure and risk of heart failure in the elderly
CU Chae, MA Pfeffer, RJ Glynn, GF Mitchell, JO Taylor, CH Hennekens
Jama 281 (7), 634-643, 1999
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with …
T Stürmer, M Joshi, RJ Glynn, J Avorn, KJ Rothman, S Schneeweiss
Journal of clinical epidemiology 59 (5), 437. e1-437. e24, 2006
The system can't perform the operation now. Try again later.
Articles 1–20